K
Kamalneet Kaur
Researcher at Maharishi Markandeshwar University, Mullana
Publications - 15
Citations - 873
Kamalneet Kaur is an academic researcher from Maharishi Markandeshwar University, Mullana. The author has contributed to research in topics: Biological activity & Antimicrobial. The author has an hindex of 10, co-authored 15 publications receiving 709 citations.
Papers
More filters
Journal ArticleDOI
Pyrazole containing natural products: Synthetic preview and biological significance
TL;DR: The present review is an attempt to understand the chemistry along with medicinal importance of pyrazole containing natural products reported till date which would certainly help the scientific community to bring further developments in the isolation and synthetic methodologies for pyrazoles based novel bioactive compounds.
Journal ArticleDOI
Isoxazoline containing natural products as anticancer agents: a review.
TL;DR: This review mainly focuses on the existence of isoxazoline derivatives in natural sources, their isolation and uses there of as anticancer agents besides highlighting the synthetic pathways to achieve these compounds.
Journal ArticleDOI
Trifluoromethylpyrazoles as anti-inflammatory and antibacterial agents: A review
TL;DR: In the recent past trifluoromethyl pyrazoles have gained much attention, particularly as anti-inflammatory and antibacterial agents, in the field of medicinal chemistry.
Journal ArticleDOI
Synthesis and biological evaluation of some 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-arylethanones: antibacterial, DNA photocleavage, and anticancer activities.
Vinod Kumar,Kamalneet Kaur,Deepkamal N. Karelia,Vikas Beniwal,Girish Kumar Gupta,Arun Sharma,A. K. Gupta +6 more
TL;DR: Regioselective synthesis of a series of 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-arylethanones 4a-k has been achieved under facile, extremely mild and greener reaction conditions with excellent yields and the compound 4j was found to be cytotoxic to all the cancer cell lines, except SKOV3, with more selectivity towards the colon cancer cell Lines and A549 lung cancer cell line.
Journal ArticleDOI
Developments in synthesis of the anti-inflammatory drug, celecoxib: a review
TL;DR: The present review would be beneficial for scientific community for further developments in the synthetic methodologies for Celecoxib and to explore some novel celecoxib based biologically active agents.